A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma.
Schuetze SM, Ballman KV, Heise R, Ganjoo KN, Davis EJ, George S, Burgess MA, Choy E, Shepard DR, Tinoco G, Hirbe A, Kelly CM, Attia S, Deshpande HA, Schwartz GK, Siontis BL, Riedel RF, von Mehren M, Kozlowski E, Chen HX, Astbury C, Rubin BP.
Schuetze SM, et al. Among authors: astbury c.
Clin Cancer Res. 2024 Oct 15;30(20):4584-4592. doi: 10.1158/1078-0432.CCR-23-3817.
Clin Cancer Res. 2024.
PMID: 38446990
Clinical Trial.